Sign in

NCT00188539Active, not recruitingPhase 2

Cervix: Hypoxia, Interstitial Fluid Pressure and GSH Levels

Predictive Assays in Cervix Cancer: Assessment of Hypoxia, Interstitial Fluid Pressure, and GSH Levels

Source: ClinicalTrials.gov · Last updated 6 Mar 2026

Brief summary (registry, in English)

The aim of this study is to measure the oxygen content and interstitial fluid pressure in cervix cancer patients. Tumour oxygen content and internal pressure of tumours may be an important factor that influences the effectiveness of radiotherapy and other treatments.

Status (registry)
Active, not recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
346 (actual)
First submitted
12 Sept 2005
Start date
Dec 1995
Primary completion date
Dec 2027
Lead sponsor
University Health Network, Toronto
NCT number
NCT00188539

What you commit to

  • Study type: Interventional · Phase 2
  • Participants enrolled: 346
  • From Dec 1995 to the primary completion date, Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients with clinically occult cervix carcinoma

Who the study is looking for

  • Newly diagnosed patients with carcinoma of the cervix ( 3 cm in size or larger) where an examination under anesthesia is to be performed for staging purposes
  • Informed consent

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Princess Margaret Hospital
Coordinator of this site? Confirm its status		TorontoCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.